BlackRock Institutional Trust Company, N.A. - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 93 filers reported holding PARATEK PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 3.64 and the average weighting 0.7%.

Quarter-by-quarter ownership
BlackRock Institutional Trust Company, N.A. ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$4,812,000
+58.4%
312,491
+33.9%
0.00%
Q3 2016$3,037,000
+54.6%
233,401
+65.3%
0.00%
Q2 2016$1,964,000
-0.2%
141,176
+8.8%
0.00%
Q1 2016$1,968,000
-20.8%
129,733
-0.9%
0.00%
Q4 2015$2,484,000
+4.2%
130,961
+4.3%
0.00%
Q3 2015$2,385,000
+4.3%
125,535
+41.5%
0.00%
Q2 2015$2,286,000
+652.0%
88,708
+1024.7%
0.00%
Q4 2014$304,0007,8870.00%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Omega Fund Management, LLC 2,138,872$55,119,00027.83%
Abingworth LLP 1,301,413$33,524,00015.22%
Roumell Asset Management, LLC 207,703$5,353,0009.43%
GREAT POINT PARTNERS LLC 415,338$10,703,0004.17%
Aisling Capital LLC 682,680$17,593,0002.62%
Broadfin Capital, LLC 530,283$13,665,0000.73%
Baupost Group 1,544,498$39,802,0000.66%
Tekla Capital Management LLC 691,000$17,807,0000.64%
GENERAL AMERICAN INVESTORS CO INC 277,076$7,140,0000.59%
Lombard Odier Asset Management (USA) Corp 140,000$3,607,0000.26%
View complete list of PARATEK PHARMACEUTICALS INC shareholders